Hattenbergstr. 10
55122 Mainz
E-Mail: pharma@schott.com
Internet: www.schott-pharma.com
Ansprechpartner
Timo Borsch+49/151/52470228
Global Product Marketing & Campaign Expert
Firmenprofil
Human health matters. That is why SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world. Every minute, more than 25,000 people receive an injection packed in a SCHOTT Pharma product.
The portfolio comprises drug containment solutions and delivery systems for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules. Every day, a team of around 4,700 people from over 60 nations works at SCHOTT Pharma to contribute to global healthcare. The company is represented in all main pharmaceutical hubs with 17 manufacturing sites in Europe, North and South America, and Asia. With over 1,000 patents and technologies developed in-house and a state-of-the-art R&D center in Switzerland, the company is focused on developing innovations for the future.
SCHOTT Pharma AG & Co. KGaA is headquartered in Mainz, Germany and listed on the Frankfurt Stock Exchange as part of the SDAX. It is majority owned by SCHOTT AG, which is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment. Currently, SCHOTT Pharma has over 1,800 customers including the top 30 leading pharma manufacturers for injectable drugs and generated revenue of EUR 957 million in the fiscal year 2024.
Further information at www.schott-pharma.com
Leistungsspektrum:
 | Aufbewahrung (für Lager und Transport) | Container | ||
| Medizinprodukte / Medical Devices | Spritzen | ||
| Packmittel / Material | Glas | ||
| Kunststoff | ||||
| Primärverpackungen | Fläschchen / Vials | ||
Videos
